SG-1 was previously identified as a potent Non-nucleoside reverse transcriptase inhibitors (NNRTI) which works through inhibition of reverse transcriptase (RT) RNA-dependent DNA polymerase activity via a direct binding event. To further investigate the relationship between its structure and activity, four series of novel analogues were designed and synthesized with 12 of them inhibiting HIV-1 replication
SG-1以前被确定为有效的非核苷类逆转录酶
抑制剂(NNRTI),可通过直接结合事件抑制逆转录酶(RT)RNA依赖性
DNA聚合酶的活性发挥作用。为了进一步研究其结构与活性之间的关系,设计并合成了四个系列的新类似物,其中有12个抑制HIV-1复制的IC50在0.09-6.71μM范围内。化合物4b,4c,4f,2和6b在两种抗NNRTI的HIV-1菌株和一种抗NNRTI的超级细菌中进行了进一步测试。结果表明,RT-E138K / M184V突变病毒对4c,4f,2和6b的抵抗力为4.7-9.1倍,但对4b的抵抗力仅为2倍,优于SG-1。